Avinger Full Year 2022 Earnings: US$4.36 loss per share (vs US$4.57 loss in FY 2021)

Simply Wall St

March 17, 2023

Avinger (NASDAQ:AVGR) Full Year 2022 Results

Key Financial Results

Revenue: US$8.27m (down 18% from FY 2021).
Net loss: US$27.2m (loss widened by 26% from FY 2021).
US$4.36 loss per share.

earnings-and-revenue-history — NasdaqCM:AVGR Earnings and Revenue History March 17th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Avinger shares are down 5.8% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 3 warning signs for Avinger that you should be aware of.

If you're looking to trade Avinger, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqCM:AVGR

Avinger

A commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany.

See The Free Research Report

Moderate with mediocre balance sheet.

See The Free Research Report